Header cover image

Japanese (NIKKEI) Life Sciences Industry Analysis

UpdatedFeb 21, 2024
DataAggregated Company Financials
Companies16
  • 7D1.2%
  • 3M-6.3%
  • 1Y-30.2%
  • YTD-2.7%

Over the last 7 days, the Life Sciences industry has risen 1.1%, driven by gains from Chiome Bioscience of 24%. In the same time, Linical was down 13%. However, the industry is down 32% over the past year. Looking forward, earnings are forecast to grow by 14% annually.

Industry Valuation and Performance

Has the Japanese Life Sciences Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Wed, 21 Feb 2024JP¥235.4bJP¥155.3bJP¥8.7b15.1x27.1x1.5x
Fri, 19 Jan 2024JP¥224.4bJP¥167.1bJP¥8.5b15.3x26.4x1.3x
Sun, 17 Dec 2023JP¥229.5bJP¥167.1bJP¥8.5b14.8x27x1.4x
Tue, 14 Nov 2023JP¥236.0bJP¥168.1bJP¥9.1b14.8x25.9x1.4x
Thu, 12 Oct 2023JP¥235.3bJP¥179.3bJP¥12.8b15x18.4x1.3x
Sat, 09 Sep 2023JP¥264.9bJP¥179.3bJP¥12.8b16.6x20.7x1.5x
Mon, 07 Aug 2023JP¥274.7bJP¥179.8bJP¥13.7b17.5x20x1.5x
Wed, 05 Jul 2023JP¥282.5bJP¥178.5bJP¥16.2b17.5x17.4x1.6x
Fri, 02 Jun 2023JP¥288.6bJP¥178.3bJP¥16.2b17.5x17.8x1.6x
Sun, 30 Apr 2023JP¥286.2bJP¥174.9bJP¥16.5b16.5x17.4x1.6x
Tue, 28 Mar 2023JP¥310.5bJP¥171.9bJP¥13.3b16.5x23.4x1.8x
Thu, 23 Feb 2023JP¥307.3bJP¥171.6bJP¥13.2b16.7x23.2x1.8x
Sat, 21 Jan 2023JP¥282.9bJP¥166.1bJP¥16.2b15x17.5x1.7x
Mon, 19 Dec 2022JP¥312.4bJP¥166.1bJP¥16.2b15.3x19.3x1.9x
Wed, 16 Nov 2022JP¥315.9bJP¥164.7bJP¥15.2b15.1x20.8x1.9x
Fri, 14 Oct 2022JP¥305.2bJP¥160.1bJP¥12.4b16.3x24.7x1.9x
Sun, 11 Sep 2022JP¥341.6bJP¥159.7bJP¥12.3b19.2x27.9x2.1x
Tue, 09 Aug 2022JP¥313.2bJP¥160.1bJP¥12.8b19.2x24.4x2x
Thu, 07 Jul 2022JP¥277.7bJP¥152.7bJP¥11.2b17.3x24.8x1.8x
Sat, 04 Jun 2022JP¥254.2bJP¥152.7bJP¥10.9b18.4x23.3x1.7x
Mon, 02 May 2022JP¥247.0bJP¥152.3bJP¥11.4b20.1x21.7x1.6x
Wed, 30 Mar 2022JP¥242.5bJP¥144.9bJP¥10.6b21.8x22.8x1.7x
Fri, 25 Feb 2022JP¥218.7bJP¥144.7bJP¥10.5b17.8x20.8x1.5x
Sun, 23 Jan 2022JP¥242.1bJP¥136.0bJP¥6.8b19.8x35.9x1.8x
Tue, 21 Dec 2021JP¥262.0bJP¥136.0bJP¥6.8b22.7x38.8x1.9x
Thu, 18 Nov 2021JP¥350.0bJP¥135.7bJP¥7.0b28x50.2x2.6x
Sat, 16 Oct 2021JP¥375.5bJP¥198.7bJP¥8.1b25.9x46.5x1.9x
Mon, 13 Sep 2021JP¥388.5bJP¥202.2bJP¥5.2b25.7x75.3x1.9x
Wed, 11 Aug 2021JP¥353.5bJP¥201.8bJP¥5.0b26x70.1x1.8x
Sun, 06 Jun 2021JP¥321.0bJP¥194.0bJP¥2.5b29.5x130.5x1.7x
Wed, 10 Mar 2021JP¥287.0bJP¥191.7bJP¥152.2m30.2x1885.7x1.5x
Price to Earnings Ratio

1885.7x


Total Market Cap: JP¥287.0bTotal Earnings: JP¥152.2mTotal Revenue: JP¥191.7bTotal Market Cap vs Earnings and Revenue0%0%0%
Japanese Life Sciences Industry Price to Earnings3Y Average 90.6x202220232024
Current Industry PE
  • Investors are pessimistic on the Japanese Life Sciences industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 27.1x which is lower than its 3-year average PE of 90.7x.
  • The 3-year average PS ratio of 1.7x is higher than the industry's current PS ratio of 1.5x.
Past Earnings Growth
  • The earnings for companies in the Life Sciences industry have grown 285% per year over the last three years.
  • Meanwhile revenues for these companies have declined 6.8% per year.
  • This means that less sales are being generated overall, but since cost of doing business is lower, profits have been increasing.

Industry Trends

Which industries have driven the changes within the Japanese Healthcare industry?

JP Market0.74%
Healthcare1.67%
Life Sciences1.24%
Clinical Research and Equipment1.24%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
2395 Shin Nippon Biomedical LaboratoriesJP¥1.63k2.7%
+JP¥1.8b
-37.7%PE12.3x
7079 WDB cocoJP¥4.83k7.6%
+JP¥817.7m
-10.2%PE15x
4583 Chiome BioscienceJP¥160.006.7%
+JP¥526.3m
-24.9%PS12.3x
2370 MEDINETJP¥46.002.2%
+JP¥253.7m
-37.8%n/a
4572 Carna BiosciencesJP¥445.003.2%
+JP¥240.0m
-9.0%PS4.7x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

7707

JP¥204.00

Precision System Science

7D

-7.7%

1Y

-46.0%

4892

JP¥704.00

Cyfuse Biomedical K.K

7D

-2.5%

1Y

-29.9%

6090

JP¥653.00

Human Metabolome Technologies

7D

-0.9%

1Y

-6.4%

130A

JP¥2,764.00

Veritas In Silico

7D

-12.9%

1Y

n/a

6190

JP¥472.00

PhoenixBio

7D

1.7%

1Y

-25.6%

4880

JP¥1,241.00

CellSource

7D

-1.0%

1Y

-65.1%

2183

JP¥447.00

Linical

7D

-14.9%

1Y

-35.7%

4583

JP¥160.00

Chiome Bioscience

7D

6.7%

1Y

-24.9%

4241

JP¥823.00

atect

7D

-5.4%

1Y

56.5%

7079

JP¥4,830.00

WDB coco

7D

7.6%

1Y

-10.2%

4572

JP¥445.00

Carna Biosciences

7D

3.2%

1Y

-9.0%

2397

JP¥797.00

DNA Chip Research

7D

2.3%

1Y

-10.7%

4570

JP¥450.00

Immuno-Biological Laboratories

7D

1.8%

1Y

0.4%

2395

JP¥1,630.00

Shin Nippon Biomedical Laboratories

7D

2.7%

1Y

-37.7%

2309

JP¥2,640.00

CMIC HOLDINGS

7D

-0.04%

1Y

51.3%

2370

JP¥46.00

MEDINET

7D

2.2%

1Y

-37.8%